4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000581
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-05-23 | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | D | ||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-05-28 | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | D | ||
Loading xslF345X03/form4-05282019_010542.xml…